Jeffrey Poulton
Director of Finance/CFO at ALNYLAM PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2024-04-29
Jeffrey Poulton active positions
Companies | Position | Start | End |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-08-12 | - |
Comptroller/Controller/Auditor | 2019-08-12 | - | |
CERVOMED INC. | Director/Board Member | 2023-08-15 | - |
Independent Dir/Board Member | 2023-08-15 | - | |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Director/Board Member | 2019-08-12 | - |
Career history of Jeffrey Poulton
Former positions of Jeffrey Poulton
Companies | Position | Start | End |
---|---|---|---|
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Director of Finance/CFO | 2017-12-31 | 2019-03-31 |
SHIRE | Director/Board Member | 2015-04-28 | 2017-12-30 |
Director of Finance/CFO | 2002-12-31 | 2017-12-30 | |
Public Communications Contact | 2002-12-31 | - | |
Q32 BIO INC. | Director/Board Member | 2020-07-20 | - |
Independent Dir/Board Member | 2020-07-20 | - |
Training of Jeffrey Poulton
Duke University | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Statistics
International
United States | 7 |
Ireland | 2 |
United Kingdom | 2 |
Operational
Director/Board Member | 5 |
Director of Finance/CFO | 3 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 6 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Health Technology |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
CervoMed, Inc. |
- Stock Market
- Insiders
- Jeffrey Poulton
- Experience